Lifescan May Be Misleading Customers About SureStep Recall, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
Purchasers of Lifescan's SureStep home glucose monitors may be "misled" by the firm's recall, which the Johnson & Johnson subsidiary "has characterized...as a product replacement program," FDA cautioned in a July 28 press release following up the company's June 4 Class I recall.